Robotic Rehabilitation and Brain Stimulation for Children With Hemiparetic Cerebral Palsy (RoboCP)
Hemiplegic Cerebral Palsy, Perinatal Stroke
About this trial
This is an interventional treatment trial for Hemiplegic Cerebral Palsy focused on measuring robotic rehabilitation, tDCS, non-invasive brain stimulation
Eligibility Criteria
Inclusion Criteria:
- confirmed diagnosis of hemiparetic cerebral palsy due to unilateral perinatal stroke
- age 6-18 years
- Manual Ability Classification System (MACS) Level I-III
- Modified Ashworth Score in shoulder and elbow <=3;
- Visual acuity (corrected) better than 20/50 in both eyes
- able to follow instructions and comply with protocol;
- able to give consent/assent;
- able to commit to all assessment and intervention sessions.
Exclusion Criteria:
- significant contractures in the upper extremity;
- other neurological conditions or active medical disease;
- unstable epilepsy;
- contraindications to tDCS;
- botulinum toxin A injections in the upper extremity in the past 6 months;
- upper extremity surgical intervention in past 6 months;
- involvement in another interventional study.
Sites / Locations
- Alberta Children's HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
Robot + tDCS
Robot + sham tDCS
10 sessions of 1.5 hrs of robotic therapy within a 3 week period, with 20 minutes of 1mA cathodal tDCS applied to the contralesional M1 area during first 20 minutes of robotic therapy. Robotic therapy will be conducted using the Kinarm Exoskeleton robot and use games to target unilateral and bilateral motor and sensory impairments.
10 sessions of 1.5 hrs of robotic therapy within a 3 week period with 20 minutes of SHAM tDCS applied during the first 20 minutes of the robotic therapy. As with experimental arm, electrode will be placed on contralesional M1. Current will ramp up and then immediately ramp down to simulate the cutaneous sensations felt with actual tDCS. Robotic therapy will be delivered with Kinarm Exoskeleton robot and use games to target unilateral and bilateral motor and sensory impairments.